CIK 0002075320 · <br>Emerging growth company
Polaryx Therapeutics, Inc.
Sign in to watch- Ticker
- PLYX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- WY
- Entity type
- operating
- Phone
- 201-940-7236
- Business address
- 140 EAST RIDGEWOOD AVENUE, SUITE 415, SOUTH TOWER, PARAMUS, NJ, 07652
- 8-K Event Shareholder vote results
- 8-K Event Regulation FD disclosure · Other events
- 10-Q Report Quarterly Report
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Executive or director change
- 8-K Event Director nominations · Other events
- 4 Insider Changes in Ownership
- 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure
- 10-Q Report Quarterly Report
- 10-K Report Annual Report
- 4 Insider Changes in Ownership
- SCHEDULE 13D Stake Beneficial Ownership Report
- 424B4 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 1 of 2 · 35 filings